AzTrials
AzTrials

HyperlipidemiaADLNCT05990595

Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control

A study testing Adlay with white rice and white rice in people with Hyperlipidemia and Hyperglycemia, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study explores the efficacy of domestic adlay in improving blood sugar and lipids metabolism, cardiovascular function, and weight control in people with high blood pressure, hyperlipidemia, and hyperglycemia. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Hyperlipidemia, Hyperglycemia, Type 2 Diabetes
What is being tested?
Adlay with white rice and white rice
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteTaiwan
Study dates
7 Jul 2023to 30 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Hyperlipidemia: Levels of LDL-choleterol equal or greater than 130 mg/dL, or triglyceride equal or greater than 150 mg/dL
  • Hyperglycemia: fasting glucose equal or greater than 100 mg/dL

Who cannot join

  • Secondary hyperglycemia Secondary hyperlipidemia

Trial locations and contacts

1 site in 1 country.

Ta-Chen Su, MD, PhD contact

+886-972651062

tachensu@gmail.com

Cheng-Yu Chiang, MSc contact

+886-965813735

oldchiang@gmail.com

Taiwan1 site, 1 recruiting
  • National Taiwan University Hospital

    Taipei, 10002

    Ta-Chen Su, MD, PhD, +886-972651062, tachensu@gmail.com

    Cheng-Yu Chiang, MSc, +886-965813735, oldchiang@gmail.com

    Recruiting

Other trials in Taiwan

About this study

Official title: Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control (ADL)

This study explores the efficacy of domestic adlay in improving blood sugar and lipids metabolism, cardiovascular function, and weight control in people with high blood pressure, hyperlipidemia, and hyperglycemia.

Through two weeks of cooked adlay-rice and white rice by a randomized cross-over design to evaluate the lipid- and glucose-lowering effects of adlay on patient with hyperlipidemia and/or hyperglycemia.

Read the detailed description

Evaluation of health effects of domestic adlay on lowering cholesterol and blood sugar

Hyperlipidemia and diabetes are major risk factors for cardiovascular disease. Clinical experiments have preliminarily proved that phytosterols can help lower blood lipids, and adlay is one of the domestic economic crops that has animal experimental evidence or theoretical potential to be beneficial to blood lipids and blood sugar control, which needs to be further explored and verified. This study explores the efficacy of domestic adlay in improving blood sugar and lipids metabolism, cardiovascular function, and weight control in people with high blood pressure, hyperlipidemia, and hyperglycemia.

We plan to recruit 60 patients with hyperglycemia or hyperlipidemia. aged between 20 and 80 years old, from National Taiwan University Hospital. This study is focused on high blood cholesterol, triglycerides, and hyperglycemia groups, thus participants must have higher cholesterol, triglycerides, or higher fasting blood glucose concentration even under currently stable treatment for at least 6 months. Lipid-lowering and hypoglycemic medication cannot be changed during this trial.

The clinical trial adopts a randomized cross-over trial, the experimental group to eat white rice with adlay and the control group to eat white rice. Participants in the project were randomly divided into two groups, group A and B, with 30 people in each group. Group A eat adlay to replace their carbohydrates: a box of 200 grams of rice (the amount of rice in dry weight is 36 grams of adlay and 54 grams of white rice) per day; Group B ate a box of 200 grams of white rice (the amount of rice was 87 grams based on dry weight) per day. After the first run of study, all participants resume to the original regular diet for two weeks, and then switch groups for crossover trial after the two-week washout period. In the experiment, during the crossover experiment, group A and group B replaced the experimental ingredients, that is, the original white rice group was replaced by adlay with white rice, and the original adlay and white rice group was replaced with white rice for a period of two weeks. To ensure that the test material is homogeneous and uniform, the white rice with adlay is made from the "cooked rice with adlay" produced by Nanqiao Group, HUACIANG INDUSTRY CO., LTD. The adlay cooked rice contains 40% adlay and Taichung No. 194 white rice 60%, and the control group used Taichung No. 194 white rice.

Every participant have to receive blood and urine sampling for biochemical measurement in each stage, 1. Baseline, 2. Two weeks after first stage: adlay with white rice or white rice, 3. Washed period stage for 2 weeks, 4. Two weeks after crossover stage. The main results analysis includes fasting blood sugar,glycosylated hemoglobin, glycosylated hemoglobin, triglycerides, total cholesterol, high-density cholesterol, and low-density cholesterol. Secondary outcome analysis includes blood pressure, body composition analysis, inflammation index, thyroid function, levels of intestinal hormones (cholecystokinin, gastrin) and glucagon-like peptide-1, and other emerging blood lipid indicators, such as small-dense LDL-C. The above measurements will be performed every 2 weeks for each stage. Pittsburgh Sleep Quality Index and Center for Epidemiological Studies Depression Scale (CES-D) will also be assessed every 2 weeks for each stage.

Keywords: hyperlipidemia, hyperglycemia, diabetes mellitus, randomized crossover trial

Being tested
Adlay with white rice, white rice
Keywords
Adlay, Hyperlipidemia, Hyperglycemia
Medical subject headings
Hyperlipidemias, Hyperglycemia, Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Adlay with white riceDietary supplement

    We will investigate the lipid- and glucose-lowering effects of Adlay rice in comparison to white rice through a randomized cross-over trial.

  • white riceDietary supplement

    white rice

Study groups in NCT05990595
Study groupRoleWhat they receive
Adlay with white riceExperimentalGroup A eat cooked adlay with white rice to replace their carbohydrates: a box of 200 grams of adlay rice per day
Receives: Dietary Supplement: Adlay with white rice
White ricePlacebo comparatorGroup B ate a box of 200 grams of cooked white rice per day
Receives: Dietary Supplement: white rice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fasting blood glucose

    glucose-lowering effects

    Measured: 2 weeks for each stage

  2. Cholesterol

    Lipids

    Measured: 2 weeks for each stage

  3. HDL-cholesterol

    Lipids

    Measured: 2 weeks for each stage

  4. LDL-cholesterol

    Lipids

    Measured: 2 weeks for each stage

  5. Triglycerides

    Lipids

    Measured: 2 weeks for each stage

  6. Glycosylated hemoglobin (HbA1C)

    Hemoglobin A1C is a form of hemoglobin (Hb) that is chemically linked to sugar

    Measured: 2 weeks for each stage

Secondary outcomes (7)
  1. Blood pressure

    physiological biomarkers

    Measured: 2 weeks for each stage

  2. Body composition

    The percentages of fat, bone and muscle in human bodies by bioelectric impedance technology

    Measured: 2 weeks for each stage

  3. hs-CRP (high sensitivity C-reactive protein)

    Inflammation

    Measured: 2 weeks for each stage

  4. Free T4 and TSH (Thyroid Stimulating Hormone)

    Thyroid function tests

    Measured: 2 weeks for each stage

  5. Insulin

    A peptide hormone produced by beta cells of the pancreatic islets

    Measured: 2 weeks for each stage

  6. Gastrin, Cholecystokinine, and Glucagon-like peptide 1

    Intestin Hormones

    Measured: 2 weeks for each stage

  7. Small-dense LDL-cholesterol

    LDL subpopulation particles

    Measured: 2 weeks for each stage

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2023
  2. Study start7 Jul 2023
  3. Primary completion28 Sep 2023 (estimated)
  4. Study completion30 Nov 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
The clinical trial adopts a randomized cross-over trial, the experimental group to eat white rice with adlay and the control group to eat white rice. Participants in the project were randomly divided into two groups, group A and B, with 30 people in each group. Group A eat 200 gm cooked adlay with white rice to replace their carbohydrates; Group B ate a box of 200 grams of white rice per day. After the first run of study, all participants resume to the original regular diet for two weeks, and then switch groups for crossover trial after the two-week washout period. In the experiment, during the crossover experiment, group A and group B replaced the experimental ingredients, that is, the original white rice group was replaced by adlay with white rice, and the original adlay and white rice group was replaced with white rice for a period of two weeks.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05990595
Sponsor's protocol ID
202206033RINC
Acronym
ADL
Status last verified
Jul 2023
First submitted
24 Jul 2023
Last updated
21 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Adlay with white rice and white rice in people with Hyperlipidemia and Hyperglycemia, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ta-Chen Su, MD, PhD (+886-972651062, tachensu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fasting blood glucose (time frame: 2 weeks for each stage). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in